| eluxadoline 100 MG Oral Tablet [Viberzi] eluxadoline | 519 | 10.2%
| T4 | 55.9% | 7,023 |
| acoramidis 356 MG Oral Tablet [Attruby] acoramidis | 517 | 10.2%
| T4 | 97.8% | - |
| desoximetasone 0.0005 MG/MG Topical Gel desoximetasone | 514 | 10.1%
| T3 | 0% | 27,754 |
| revefenacin 0.0583 MG/ML Inhalation Solution [Yupelri] revefenacin | 513 | 10.1%
| T5 | 100% | 1,274 |
| 0.8 ML adalimumab-aaty 100 MG/ML Auto-Injector [Yuflyma] adalimumab-aaty | 513 | 10.1%
| T4 | 100% | - |
| {3 (0.8 ML adalimumab-aaty 100 MG/ML Auto-Injector [Yuflyma]) } Pack [Yuflyma Auto-Injector 80 MG/0.8 ML Starter Package for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa] adalimumab-aaty | 513 | 10.1%
| T4 | 100% | - |
| 0.2 ML adalimumab-aaty 100 MG/ML Prefilled Syringe [Yuflyma] adalimumab-aaty | 513 | 10.1%
| T4 | 100% | - |
| 0.4 ML adalimumab-aaty 100 MG/ML Prefilled Syringe [Yuflyma] adalimumab-aaty | 513 | 10.1%
| T4 | 100% | - |
| 0.4 ML adalimumab-aaty 100 MG/ML Auto-Injector [Yuflyma] adalimumab-aaty | 513 | 10.1%
| T4 | 100% | - |
| 1 ML denosumab-bnht 60 MG/ML Prefilled Syringe [Conexxence] denosumab-bnht | 503 | 9.9%
| T2 | 0% | - |
| amoxicillin 25 MG/ML / clavulanate 6.25 MG/ML Oral Suspension [Augmentin] amoxicillin | 502 | 9.9%
| T3 | 0% | 6,202,496 |
| tirbanibulin 0.01 MG/MG Topical Ointment [Klisyri] tirbanibulin | 501 | 9.9%
| T4 | 12.3% | 1,900 |
| Once-Daily gabapentin 600 MG Oral Tablet Once-Daily gabapentin | 498 | 9.8%
| T3 | 84.8% | - |
| diclofenac sodium 20 MG/ML Topical Solution diclofenac sodium | 497 | 9.8%
| T4 | 72% | 3,196,668 |
| tobramycin 0.003 MG/MG Ophthalmic Ointment [Tobrex] tobramycin | 490 | 9.7%
| T4 | 0% | 195,319 |
| 3 ML insulin glargine 300 UNT/ML Pen Injector insulin glargine | 488 | 9.6%
| T3 | 1.9% | - |
| 1.5 ML insulin glargine 300 UNT/ML Pen Injector insulin glargine | 488 | 9.6%
| T3 | 1.9% | - |
| lidocaine 0.018 MG/MG Medicated Patch [ZTlido] lidocaine | 483 | 9.5%
| T3 | 93.9% | 481,042 |
| Once-Daily gabapentin 300 MG Oral Tablet Once-Daily gabapentin | 482 | 9.5%
| T3 | 87.5% | - |
| adapalene 1 MG/ML Topical Cream adapalene | 481 | 9.5%
| T3 | 17.8% | 4,155 |
| nitisinone 4 MG/ML Oral Suspension [Orfadin] nitisinone | 480 | 9.5%
| T4 | 66.7% | - |
| 24 HR desvenlafaxine 50 MG Extended Release Oral Tablet desvenlafaxine | 477 | 9.4%
| T3 | 3.4% | - |
| 24 HR desvenlafaxine 100 MG Extended Release Oral Tablet desvenlafaxine | 477 | 9.4%
| T3 | 3.4% | - |
| 0.8 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo] adalimumab-adbm | 476 | 9.4%
| T4 | 100% | - |
| 0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector [Cyltezo] adalimumab-adbm | 476 | 9.4%
| T4 | 100% | - |
| 0.2 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo] adalimumab-adbm | 476 | 9.4%
| T4 | 100% | - |
| 0.4 ML adalimumab-adbm 50 MG/ML Prefilled Syringe [Cyltezo] adalimumab-adbm | 476 | 9.4%
| T4 | 100% | - |
| 0.4 ML adalimumab-adbm 100 MG/ML Prefilled Syringe [Cyltezo] adalimumab-adbm | 476 | 9.4%
| T4 | 100% | - |
| 0.4 ML adalimumab-adbm 100 MG/ML Auto-Injector [Cyltezo] adalimumab-adbm | 476 | 9.4%
| T4 | 100% | - |
| 250 MG estradiol 0.001 MG/MG Topical Gel estradiol | 474 | 9.4%
| T4 | 0% | - |
| sargramostim 0.25 MG/ML Injectable Solution [Leukine] sargramostim | 473 | 9.3%
| T4 | 74.1% | 113 |
| Sensor 3 ML insulin lispro-aabc 100 UNT/ML Pen Injector [Lyumjev] Sensor | 472 | 9.3%
| T3 | 1.9% | 3,723 |
| 500 MG estradiol 0.001 MG/MG Topical Gel estradiol | 470 | 9.3%
| T4 | 0% | - |
| 1000 MG estradiol 0.001 MG/MG Topical Gel estradiol | 470 | 9.3%
| T4 | 0% | - |
| 750 MG estradiol 0.001 MG/MG Topical Gel estradiol | 470 | 9.3%
| T4 | 0% | - |
| 1250 MG estradiol 0.001 MG/MG Topical Gel estradiol | 464 | 9.2%
| T4 | 0% | - |
| 0.14 ML risperidone 357 MG/ML Prefilled Syringe [Uzedy] risperidone | 463 | 9.1%
| T4 | 21.3% | 1,164 |
| 0.21 ML risperidone 357 MG/ML Prefilled Syringe [Uzedy] risperidone | 463 | 9.1%
| T4 | 21.3% | 1,164 |
| 0.28 ML risperidone 357 MG/ML Prefilled Syringe [Uzedy] risperidone | 463 | 9.1%
| T4 | 21.3% | 1,164 |
| 0.35 ML risperidone 357 MG/ML Prefilled Syringe [Uzedy] risperidone | 463 | 9.1%
| T4 | 21.3% | 1,164 |
| 0.42 ML risperidone 357 MG/ML Prefilled Syringe [Uzedy] risperidone | 463 | 9.1%
| T4 | 21.3% | 1,164 |
| 0.56 ML risperidone 357 MG/ML Prefilled Syringe [Uzedy] risperidone | 463 | 9.1%
| T4 | 21.3% | 1,164 |
| 0.7 ML risperidone 357 MG/ML Prefilled Syringe [Uzedy] risperidone | 463 | 9.1%
| T4 | 21.3% | 1,164 |
| 0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio] vedolizumab | 462 | 9.1%
| T5 | 98.5% | 2,238 |
| griseofulvin 165 MG Oral Tablet griseofulvin | 461 | 9.1%
| T3 | 0% | 1,743 |
| {8 (estradiol 0.004 MG Vaginal Insert [Imvexxy]) } Pack [Imvexxy 4 MCG Maintenance Pack] estradiol | 457 | 9%
| T3 | 10.8% | 8,850 |
| {18 (estradiol 0.004 MG Vaginal Insert [Imvexxy]) } Pack [Imvexxy 4 MCG Starter Pack] estradiol | 457 | 9%
| T3 | 10.8% | 8,850 |
| {8 (estradiol 0.01 MG Vaginal Insert [Imvexxy]) } Pack [Imvexxy 10 MCG Maintenance Pack] estradiol | 457 | 9%
| T3 | 10.8% | 8,850 |
| {18 (estradiol 0.01 MG Vaginal Insert [Imvexxy]) } Pack [Imvexxy 10 MCG Starter Pack] estradiol | 457 | 9%
| T3 | 10.8% | 8,850 |
| risdiplam 0.75 MG/ML Oral Solution [Evrysdi] risdiplam | 447 | 8.8%
| T4 | 98.8% | 424 |
| PMDD fluoxetine 10 MG Oral Tablet PMDD fluoxetine | 442 | 8.7%
| T2 | 0% | - |
| PMDD fluoxetine 20 MG Oral Tablet PMDD fluoxetine | 442 | 8.7%
| T2 | 0% | - |
| acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule acetaminophen | 441 | 8.7%
| T3 | 57.8% | 156 |
| Emollient clobetasol propionate 0.5 MG/ML Topical Foam Emollient clobetasol propionate | 436 | 8.6%
| T3 | 0% | - |
| bromfenac 0.7 MG/ML Ophthalmic Solution [Prolensa] bromfenac | 435 | 8.6%
| T3 | 0% | 144,112 |
| penicillamine 250 MG Oral Capsule penicillamine | 429 | 8.5%
| T4 | 17.9% | 162 |
| 0.9 ML tocilizumab 180 MG/ML Prefilled Syringe [Actemra] tocilizumab | 426 | 8.4%
| T4 | 100% | 109,257 |
| 0.9 ML tocilizumab 180 MG/ML Auto-Injector [Actemra] tocilizumab | 426 | 8.4%
| T4 | 100% | 109,257 |
| {7 (siponimod 0.25 MG Oral Tablet [Mayzent]) } Pack [Mayzent 1 MG Starter Pack] siponimod | 425 | 8.4%
| T3 | 72.4% | 928 |
| desoximetasone 0.0005 MG/MG Topical Ointment desoximetasone | 422 | 8.3%
| T3 | 0% | 27,754 |
| siponimod 0.25 MG Oral Tablet [Mayzent] siponimod | 422 | 8.3%
| T4 | 73.6% | 928 |
| siponimod 2 MG Oral Tablet [Mayzent] siponimod | 422 | 8.3%
| T4 | 73.6% | 928 |
| siponimod 1 MG Oral Tablet [Mayzent] siponimod | 422 | 8.3%
| T4 | 73.6% | 928 |
| {12 (siponimod 0.25 MG Oral Tablet [Mayzent]) } Pack [Mayzent 2 MG Starter Pack] siponimod | 421 | 8.3%
| T4 | 73.3% | 928 |
| 24 HR venlafaxine 225 MG Extended Release Oral Tablet venlafaxine | 419 | 8.3%
| T2 | 0% | - |
| 24 HR venlafaxine 75 MG Extended Release Oral Tablet venlafaxine | 417 | 8.2%
| T2 | 0% | - |
| fluoxetine 25 MG / olanzapine 6 MG Oral Capsule fluoxetine | 416 | 8.2%
| T3 | 7.7% | 1,427,221 |
| fluoxetine 50 MG / olanzapine 6 MG Oral Capsule fluoxetine | 416 | 8.2%
| T3 | 7.7% | 1,427,221 |
| fluoxetine 25 MG / olanzapine 12 MG Oral Capsule fluoxetine | 416 | 8.2%
| T3 | 7.7% | 1,427,221 |
| fluoxetine 50 MG / olanzapine 12 MG Oral Capsule fluoxetine | 416 | 8.2%
| T3 | 7.7% | 1,427,221 |
| fluoxetine 25 MG / olanzapine 3 MG Oral Capsule fluoxetine | 416 | 8.2%
| T3 | 7.7% | 1,427,221 |
| azithromycin 10 MG/ML Ophthalmic Solution [AzaSite] azithromycin | 415 | 8.2%
| T3 | 0% | 5,970,026 |
| betaxolol 2.5 MG/ML Ophthalmic Suspension [Betoptic S] betaxolol | 410 | 8.1%
| T3 | 2.8% | 7,458 |
| piperacillin 2000 MG / tazobactam 250 MG Injection [Zosyn] piperacillin | 408 | 8.1%
| T3 | 0% | 22,422 |
| 24 HR venlafaxine 37.5 MG Extended Release Oral Tablet venlafaxine | 406 | 8%
| T2 | 0% | - |
| itraconazole 10 MG/ML Oral Solution itraconazole | 404 | 8%
| T3 | 17.5% | 13,522 |
| caffeine 100 MG / ergotamine tartrate 2 MG Rectal Suppository [Migergot] caffeine | 403 | 8%
| T4 | 0% | 96 |
| methylnaltrexone bromide 150 MG Oral Tablet [Relistor] methylnaltrexone bromide | 400 | 7.9%
| T4 | 60.9% | 15,141 |
| 2 ML tralokinumab-ldrm 150 MG/ML Auto-Injector [Adbry] tralokinumab-ldrm | 400 | 7.9%
| T4 | 98.2% | 1,712 |
| tobramycin 75 MG/ML Inhalation Solution tobramycin | 399 | 7.9%
| T4 | 98.5% | 195,319 |
| 24 HR venlafaxine 150 MG Extended Release Oral Tablet venlafaxine | 399 | 7.9%
| T2 | 0% | - |
| imipramine pamoate 75 MG Oral Capsule imipramine pamoate | 395 | 7.8%
| T2 | 27.7% | 1,234 |
| imipramine pamoate 100 MG Oral Capsule imipramine pamoate | 395 | 7.8%
| T2 | 27.7% | 1,234 |
| imipramine pamoate 125 MG Oral Capsule imipramine pamoate | 395 | 7.8%
| T2 | 27.7% | 1,234 |
| imipramine pamoate 150 MG Oral Capsule imipramine pamoate | 395 | 7.8%
| T2 | 27.7% | 1,234 |
| {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Capsule) / 4 (ferrous fumarate 75 MG Oral Capsule) } Pack [Gemmily 28 Day] ethinyl estradiol | 394 | 7.8%
| T2 | 0% | - |
| 12 HR orphenadrine citrate 100 MG Extended Release Oral Tablet orphenadrine citrate | 391 | 7.7%
| T2 | 35.7% | - |
| 1 ML tralokinumab-ldrm 150 MG/ML Prefilled Syringe [Adbry] tralokinumab-ldrm | 388 | 7.7%
| T4 | 98.2% | 1,712 |
| diflorasone diacetate 0.0005 MG/MG Topical Ointment diflorasone diacetate | 380 | 7.5%
| T3 | 0% | 6,653 |
| ensifentrine 1.2 MG/ML Inhalation Suspension [Ohtuvayre] ensifentrine | 375 | 7.4%
| T4 | 100% | - |
| Osmotic 24 HR metformin hydrochloride 1000 MG Extended Release Oral Tablet Osmotic | 371 | 7.3%
| T2 | 5% | - |
| acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule acetaminophen | 370 | 7.3%
| T3 | 58.2% | 156 |
| betamethasone valerate 1.2 MG/ML Topical Foam betamethasone valerate | 369 | 7.3%
| T3 | 0% | 145,618 |
| methylprednisolone 2 MG Oral Tablet [Medrol] methylprednisolone | 366 | 7.2%
| T3 | 41.7% | 4,135,771 |
| flavoxate hydrochloride 100 MG Oral Tablet flavoxate hydrochloride | 366 | 7.2%
| T2 | 0% | 1,990 |
| tretinoin 0.0004 MG/MG Topical Gel tretinoin | 363 | 7.2%
| T3 | 73.3% | 91,688 |
| azelaic acid 150 MG/ML Topical Foam [Finacea] azelaic acid | 363 | 7.2%
| T4 | 0% | 37,203 |
| 24 HR metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet metformin hydrochloride | 359 | 7.1%
| T2 | 0% | - |
| 24 HR metformin hydrochloride 1000 MG / saxagliptin 5 MG Extended Release Oral Tablet metformin hydrochloride | 359 | 7.1%
| T2 | 0% | - |
| 24 HR metformin hydrochloride 500 MG / saxagliptin 5 MG Extended Release Oral Tablet metformin hydrochloride | 359 | 7.1%
| T2 | 0% | - |